Exercise Insufficient to Overcome CVD Risks of Overweight/Obesity
Physical activity cannot compensate adequately for the negative impact of excess body weight on cardiometabolic health.
FDA Approval Granted for First Long-acting Injectable HIV Therapy
Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.
FDA Update: Blood Donation During COVID-19 Pandemic
The FDA provides details on how COVID-19 infection or vaccination against the virus affects a waiting period to donate. Please share the information with your patients.
7 Myths and Facts about the COVID-19 Vaccines for PCPs and Patients
Patients trust primary care providers for accurate information on the COVID-19 vaccines. Here are 7 of the many myths now widespread you may need to explain to your patients.
A Doctor's Doctor Counsels on the Decision to Leave Practice
Michael Myers, MD, a physician to physicians, urges any clinician who, worn out by COVID-19, has thoughts of leaving medicine to seek counseling first.
Thirty-day Readmission Rate Higher for CVD Patients Who Believe it will Happen
Thirty-day hospital readmission was found to be higher among cardiovascular patients who believed readmission was highly likely vs those who did not believe so.
PCP Survey Finds Patient Vaccine Distrust High, Health Issues More Complex
A majority of primary care clinicians report their patients worry about COVID-19 vaccine side effects and the speed of vaccine development. Most do plan to be vaccinated themselves.
Fighting COVID-19 Leaves Many in Health Care Suffering Moral Injury
Treating COVID-19 patients under the most challenging physical and emotional conditions has led to a sense of moral injury for many providers, according to Dr Michael Myers.
J&J COVID-19 Single-dose Vaccine Candidate Shows Promise
Johnson & Johnson single-dose COVID-19 vaccine candidate induces durable immune response in participants aged 18 to 55 years; results support further development.
Sotagliflozin: CV Benefit Seen in Patients with T2 Diabetes, Worsening Heart Failure
Sotagliflozin reduced CV death and hospitalization for HF in patients with T2D and acute symptomatic HF when given during or immediately after hospitalization.
The COVID-19 Variants: What We Know So Far
What are the implications of the global emergence of SARS-CoV-2 variants in terms of disease severity and vaccine and treatment efficacy?
COVID-19: ACP Releases Statement on Vaccine Provision, Payment
Recommendations address the role of clinicians as vaccinators and stress as essential communication and collaboration with patients' primary care team.
Expert on Physician Mental Health Discusses COVID-19 Impact
A psychiatrist who exclusively treats health care providers describes his work during the pandemic with clinicians who are treating COVID-19 patients.
Top Content 2020: Preventive Cardiology
The most popular features in preventive cardiology this year were interviews with thought leaders on management of diabetes, hypertension, and hypercholesterolemia.
Top Content 2020: Obesity
Interviews with obesity experts, short tests of clinical and guideline knowledge, and news briefs topped the popular content on obesity on Patient Care in 2020.
NAFLD and Weight Loss: Study Quantifies Dose-response Relationship
Biomarkers of nonalcoholic fatty liver disease saw clinically meaningful improvement in a dose-response relationship with weight loss.
Pfizer & Moderna COVID-19 Vaccines: Side-by-side Comparison
The 2 FDA-approved COVID-19 vaccines are similarly effective but also very different in a number of ways that will affect distribution.
FDA Advisory Panel Recommends Expanded Use of HF Drug
An FDA panel voted to recommend the expanded use of sacubitril/valsartan for patients with heart failure with preserved ejection fraction.
Burden of Poor Social Determinants of Health Correlated with Fatal, Nonfatal CHD
Results of a new study suggest a simple clinical approach to assessing individuals at high risk of CHD who would benefit from targeted intervention.
Trust in the COVID-19 Vaccine is Fluid: KFF Vaccine Monitor Project Explains
A new Kaiser Family Foundation survey project found 85% of respondents trust their regular healthcare provider for information COVID-19 vaccination. PCPs, read more.
FDA Grants EUA for First Non-prescription, Fully-at-home COVID-19 Test Kit
The rapid antigen test for the detection of active COVID-19 in those with and without symptoms produces results within 20 minutes and will retail for about $30.
Bariatric Surgery May Improve COVID-19 Outcomes in Patients with Obesity
Among patients with obesity who contracted COVID-19, those with a history of bariatric surgery had significantly decreased odds of hospitalization, a new study finds.
How to Manage Post-COVID-19 Vaccination Reactions among Healthcare Staff
Vaccination against COVID-19 for US healthcare personnel began on December 14, 2020; the same day, CDC hosted a webinar on how to ensure HCP health and safety during this period.
State COVID-19 Vaccine Distribution Plans, Priorities
Early COVID-19 vaccine demand will far exceed supply and so states have been refining distribution plans for months. Here is a topline review of what to expect.
SGLT2 Inhibitors Enter Vast Treatment Void for High-risk CKD Patients
Patients with chronic kidney disease have had no treatment options to slow the certain progression to renal failure. Enter SGLT2 inhibitors. A key clinical trial investigator explains.
High-dose Flu Vaccine Confers No Added Benefit for Patients with CVD
A high-dose influenza vaccine was no more effective than the standard-dose vaccine at reducing the risk of severe outcomes among patients with heart disease, NIH study finds.
CDC Reduces COVID-19 Quarantine Requirement
The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.
DAPA-CKD Investigator: "PCPs Should be First-line Prescribers of SGLT2 Inhibitors"
Primary care clinicians should be the first to prescribe SGLT2 inhibitors for many reasons, as explained by Prof Jonathan McMurray in this Patient Care interview.
Professor John McMurray Highlights DAPA-CKD Trial Outcomes
DAPA-CKD investigator Professor John McMurray details the trial and renal and cardiovascular outcomes for Patient Care Online.
Baloxavir Marboxil Wins FDA Label Expansion for Post-exposure Flu Prevention
The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.